Table 5 Predictive efficacy of clinical, DLCT, and combined model for MSI status of gastric cancer
Models | AUC (95% CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
|---|---|---|---|---|
Training set | ||||
 Clinical | 0.737 (0.660~0.813) | 72.55 (37/51) | 70.68 (94/133) | 71.20 (131/184) |
 DLCT | 0.856 (0.792~0.920) | 72.55 (37/51) | 86.47 (115/133) | 82.61 (152/184) |
 Combined | 0.880 (0.820~0.939) | 80.39 (41/51) | 81.20 (108/133) | 80.98 (149/184) |
Validation set | ||||
 Clinical | 0.721 (0.596~0.846) | 78.95 (15/19) | 59.02 (36/61) | 63.75 (51/80) |
 DLCT | 0.837 (0.725~0.949) | 73.68 (14/19) | 88.52 (54/61) | 85.00 (68/80) |
 Combined | 0.879 (0.791~0.968) | 78.95 (15/19) | 75.40 (46/61) | 76.25 (61/80) |